Bulletin
Investor Alert

Tilray Inc. Cl 2

NAS: TLRY

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Oct 22, 2021, 7:59 p.m.

/zigman2/quotes/209129655/composite

$

11.03

Change

-0.05 -0.45%

Volume

Volume 180,123

Quotes are delayed by 20 min

/zigman2/quotes/209129655/composite

Previous close

$ 11.56

$ 11.08

Change

-0.48 -4.15%

Day low

Day high

$10.94

$11.53

Open

52 week low

52 week high

$5.25

$67.00

Open

Company Description

Tilray, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research, cultivation, processing, and distribution of cannabis products worldwide. Its products...

Tilray, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research, cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consist of hemp seed, hemp foods, board spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in New York, NY.

Valuation

Price to Sales Ratio

8.93

Price to Book Ratio

1.70

Enterprise Value to Sales

9.82

Total Debt to Enterprise Value

0.19

Efficiency

Revenue/Employee

244,326.00

Income Per Employee

-174,962.00

Receivables Turnover

7.73

Total Asset Turnover

0.15

Liquidity

Current Ratio

2.20

Quick Ratio

1.56

Cash Ratio

1.22

Profitability

Gross Margin

17.14

Operating Margin

-13.36

Pretax Margin

-67.15

Net Margin

-71.61

Return on Assets

-10.62

Return on Equity

-15.49

Return on Total Capital

-2.23

Return on Invested Capital

-12.05

Capital Structure

Total Debt to Total Equity

21.05

Total Debt to Total Capital

17.39

Total Debt to Total Assets

15.58

Long-Term Debt to Equity

19.94

Long-Term Debt to Total Capital

16.47

Officers and Executives

Name Age Officer Since Title
Mr. Irwin David Simon 61 2021 Chairman & Chief Executive Officer
Mr. Carl A. Merton - 2021 Chief Financial Officer
Mr. Lloyd Brathwaite - 2021 Chief Information Officer
Dr. Joshua Eades - 2014 Chief Science Officer
Dr. Catherine Jacobson - 2018 Vice President-Regulatory & Medical Affairs

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
08/19/2021 Irwin David Simon
President and CEO; Director
120,291   Derivative/Non-derivative trans. at $12.68 per share. 1,525,289
08/19/2021 Irwin David Simon
President and CEO; Director
36,088   Derivative/Non-derivative trans. at $12.68 per share. 457,595
08/19/2021 Irwin David Simon
President and CEO; Director
89,495   Derivative/Non-derivative trans. at $12.68 per share. 1,134,796
08/19/2021 James R. Meiers
Head of Canada
7,299   Derivative/Non-derivative trans. at $12.68 per share. 92,551
08/19/2021 James R. Meiers
Head of Canada
7,633   Derivative/Non-derivative trans. at $12.68 per share. 96,786
08/19/2021 Carl A. Merton
Chief Financial Officer
50,247   Derivative/Non-derivative trans. at $12.68 per share. 637,131
08/19/2021 Denise Menikheim Faltischek
Chief Strategy Officer
8,925   Derivative/Non-derivative trans. at $12.68 per share. 113,169
08/19/2021 Denise Menikheim Faltischek
Chief Strategy Officer
10,505   Derivative/Non-derivative trans. at $12.68 per share. 133,203
08/19/2021 Irwin David Simon
President and CEO; Director
242,277   Derivative/Non-derivative trans. at $0 per share. 0
08/19/2021 Irwin David Simon
President and CEO; Director
72,683   Derivative/Non-derivative trans. at $0 per share. 0
08/19/2021 Irwin David Simon
President and CEO; Director
180,251   Derivative/Non-derivative trans. at $0 per share. 0
08/19/2021 James R. Meiers
Head of Canada
31,125   Derivative/Non-derivative trans. at $0 per share. 0
08/19/2021 James R. Meiers
Head of Canada
32,548   Derivative/Non-derivative trans. at $0 per share. 0
08/19/2021 Carl A. Merton
Chief Financial Officer
96,628   Derivative/Non-derivative trans. at $0 per share. 0
08/19/2021 Denise Menikheim Faltischek
Chief Strategy Officer
26,444   Derivative/Non-derivative trans. at $0 per share. 0
08/19/2021 Denise Menikheim Faltischek
Chief Strategy Officer
31,125   Derivative/Non-derivative trans. at $0 per share. 0
08/12/2021 Irwin David Simon
President and CEO; Director
90,126   Derivative/Non-derivative trans. at $14.1 per share. 1,270,776
08/12/2021 James R. Meiers
Head of Canada
7,926   Derivative/Non-derivative trans. at $14.1 per share. 111,756
08/12/2021 Denise Menikheim Faltischek
Chief Strategy Officer
9,163   Derivative/Non-derivative trans. at $14.1 per share. 129,198
08/12/2021 Irwin David Simon
President and CEO; Director
180,251   Derivative/Non-derivative trans. at $0 per share. 0
08/12/2021 James R. Meiers
Head of Canada
32,548   Derivative/Non-derivative trans. at $0 per share. 0
08/12/2021 Denise Menikheim Faltischek
Chief Strategy Officer
26,443   Derivative/Non-derivative trans. at $0 per share. 0
08/07/2021 Irwin David Simon
President and CEO; Director
12,926   Derivative/Non-derivative trans. at $14.42 per share. 186,392
08/07/2021 Irwin David Simon
President and CEO; Director
25,852   Derivative/Non-derivative trans. at $0 per share. 0
08/05/2021 Brendan Kennedy
Director
300,000   Disposition at $14.46 per share. 4,338,000
08/04/2021 Brendan Kennedy
Director
300,000   Disposition at $14.08 per share. 4,224,000
07/16/2021 Brendan Kennedy
Director
300,000   Disposition at $14.04 per share. 4,212,000
07/15/2021 Brendan Kennedy
Director
76,289   Disposition at $15.18 per share. 1,158,067
07/15/2021 Brendan Kennedy
Director
223,711   Disposition at $14.5 per share. 3,243,809
06/18/2021 Brendan Kennedy
Director
400,000   Disposition at $17.19 per share. 6,876,000
06/17/2021 Brendan Kennedy
Director
400,000   Disposition at $17.97 per share. 7,188,000
06/03/2021 James R. Meiers
Head of Canada
23,826   Disposition at $19.64 per share. 467,942
/news/latest/company/us/tlry

MarketWatch News on TLRY

  1. MemeMarkets: “The Market of the Apes” with Dave Lauer

    3:19 p.m. Oct. 19, 2021

    - Thornton McEnery

  2. Tilray stock price target cut to $10.00 from $11.50 at Stifel Nicolaus

    7:02 a.m. Oct. 8, 2021

    - Tomi Kilgore

  3. Tilray Stock Rallies Despite a $35 Million Loss

    6:09 p.m. Oct. 7, 2021

    - Karishma Vanjani

  4. Tilray posts larger-than-expected loss

    7:18 a.m. Oct. 7, 2021

    - Steve Gelsi

  5. CORRECTED: Tilray Q1 FactSet consensus loss per share 6 cents; revenue $172.6 mln

    7:16 a.m. Oct. 7, 2021

    - Ciara Linnane

  6. Tilray says on track with at least $80 mln in cost savings from Aphria merger

    7:03 a.m. Oct. 7, 2021

    - Ciara Linnane

  7. Tilray Q1 revenue $168.0 mln vs. $117.5 mln a year ago

    7:02 a.m. Oct. 7, 2021

    - Ciara Linnane

  8. Tilray Q1 loss per share 8 cents vs. loss 9 cents a year ago

    7:02 a.m. Oct. 7, 2021

    - Ciara Linnane

  9. Canadian retail cannabis sales set record, shares rise

    10:16 a.m. Sept. 23, 2021

    - Steve Gelsi

  10. House includes cannabis banking measure in defense bill

    1:07 p.m. Sept. 22, 2021

    - Steve Gelsi

  11. Loading more headlines...
/news/nonmarketwatch/company/us/tlry

Other News on TLRY

  1. Could Another Acquisition Be on the Horizon for Tilray?

    6:35 a.m. Oct. 21, 2021

    - Motley Fool

  2. Why Canopy Growth, Tilray, and Hexo Stocks Dropped

    1:02 p.m. Oct. 20, 2021

    - Motley Fool

  3. Why Tilray Stock Climbed More Than 14% Tuesday

    4:35 p.m. Oct. 19, 2021

    - Motley Fool

  4. Cannabis Company Tilray Sets Blueprint for U.S. Expansion

    8:00 a.m. Oct. 15, 2021

    - Kristin Broughton

  5. 1 Troubling Number From Tilray's Q1 Results

    6:33 a.m. Oct. 14, 2021

    - Motley Fool

  6. Loading more headlines...

At a Glance

Tilray, Inc.

655 Madison Avenue

19th floor

New York, New York 10065

Phone

1 5193228800

Industry

Farming

Sector

Agriculture

Fiscal Year-end

05/2022

Revenue

$513.09M

Net Income

$-367.42M

2021 Sales Growth

207.3%

Employees

2,100

/news/pressrelease/company/us/tlry

Press Releases on TLRY

  1. Tilray Strengthens Leadership Position in Canada

    7:30 a.m. Oct. 19, 2021

    - BusinessWire - BZX

  2. High Tide Closes Acquisition of Blessed CBD and Enters U.K. Market

    6:35 a.m. Oct. 19, 2021

    - BusinessWire - BZX

  3. High Tide Closes Acquisition of Blessed CBD and Enters U.K. Market

    6:00 a.m. Oct. 19, 2021

    - PR Newswire - PRF

  4. High Tide Secures Non-Dilutive Credit Facility with ATB Financial

    6:00 a.m. Oct. 18, 2021

    - PR Newswire - PRF

  5. Tilray, Inc. Reports First Quarter Fiscal Year 2022 Financial Results

    7:00 a.m. Oct. 7, 2021

    - BusinessWire - BZX

  6. High Tide Enters U.K. Market Through Acquisition of Blessed CBD

    6:02 a.m. Oct. 7, 2021

    - BusinessWire - BZX

  7. Loading more headlines...
Link to MarketWatch's Slice.